Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,258 | 613 | 99.2% |
| Education | $103.50 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $5,184 | 323 | $0 (2024) |
| ABBVIE INC. | $1,600 | 68 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,162 | 60 | $0 (2024) |
| GENZYME CORPORATION | $815.73 | 20 | $0 (2023) |
| GlaxoSmithKline, LLC. | $605.87 | 28 | $0 (2024) |
| PFIZER INC. | $584.99 | 42 | $0 (2024) |
| Lilly USA, LLC | $561.44 | 27 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $426.65 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $309.76 | 7 | $0 (2021) |
| Genentech USA, Inc. | $143.96 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,616 | 72 | Amgen Inc. ($867.02) |
| 2023 | $1,726 | 82 | Amgen Inc. ($779.92) |
| 2022 | $1,501 | 89 | Amgen Inc. ($833.38) |
| 2021 | $1,010 | 65 | Amgen Inc. ($500.32) |
| 2020 | $911.85 | 44 | Amgen Inc. ($459.40) |
| 2019 | $2,572 | 143 | Amgen Inc. ($970.12) |
| 2018 | $1,858 | 87 | Amgen Inc. ($568.95) |
| 2017 | $1,168 | 34 | AbbVie, Inc. ($458.01) |
All Payment Transactions
616 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Rare Disease | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $122.62 | General |
| Category: Inflammation | ||||||
| 11/15/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Dermatology | ||||||
| 11/01/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Inflammation | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $171.22 | General |
| 10/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: Dermatology | ||||||
| 10/04/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Dermatology | ||||||
| 09/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: Inflammation | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $117.44 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 09/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Inflammation | ||||||
| 08/30/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: Inflammation | ||||||
| 08/05/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $9.76 | General |
| Category: Inflammation | ||||||
| 07/29/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Inflammation | ||||||
| 07/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 224 | 407 | $78,469 | $36,270 |
| 2022 | 4 | 278 | 503 | $97,110 | $48,260 |
| 2021 | 6 | 415 | 803 | $139,198 | $71,321 |
| 2020 | 6 | 419 | 839 | $138,017 | $62,107 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 152 | 320 | $59,437 | $29,076 | 48.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $15,933 | $6,862 | 43.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 31 | $3,100 | $332.10 | 10.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 174 | 383 | $71,138 | $36,886 | 51.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 73 | 73 | $20,769 | $9,488 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 21 | $2,603 | $1,568 | 60.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 26 | $2,600 | $317.59 | 12.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 215 | 492 | $91,384 | $49,632 | 54.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 134 | 134 | $38,152 | $17,588 | 46.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 38 | $4,709 | $2,738 | 58.1% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 13 | 19 | $2,362 | $1,009 | 42.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 15 | 23 | $2,300 | $259.93 | 11.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 13 | 97 | $291.00 | $94.38 | 32.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 207 | 481 | $89,341 | $41,015 | 45.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 135 | 135 | $38,436 | $17,480 | 45.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 27 | 36 | $4,462 | $2,141 | 48.0% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 11 | 19 | $2,362 | $992.31 | 42.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 20 | 29 | $2,900 | $322.74 | 11.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 19 | 139 | $517.00 | $156.41 | 30.3% |
About Dr. Timothy Spiegel, M.D
Dr. Timothy Spiegel, M.D is a Rheumatology healthcare provider based in Santa Barbara, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700870243.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Spiegel, M.D has received a total of $12,362 in payments from pharmaceutical and medical device companies, with $1,616 received in 2024. These payments were reported across 616 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($12,258).
As a Medicare-enrolled provider, Spiegel has provided services to 1,336 Medicare beneficiaries, totaling 2,552 services with total Medicare billing of $217,958. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Santa Barbara, CA
- Active Since 09/09/2005
- Last Updated 12/04/2007
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1700870243
Products in Payments
- Enbrel (Biological) $3,580
- Humira (Biological) $729.57
- COSENTYX (Biological) $682.14
- BENLYSTA (Biological) $605.87
- XELJANZ (Drug) $584.99
- Otezla (Drug) $511.98
- EVENITY (Biological) $478.06
- KEVZARA (Drug) $464.38
- RINVOQ (Biological) $459.11
- SAPHNELO (Biological) $426.65
- COSENTYX (Drug) $366.16
- Prolia (Biological) $333.80
- TALTZ (Drug) $282.03
- KEVZARA (Biological) $258.29
- RHEUMATOID ARTHRITIS DISEASE (Drug) $184.05
- Rinvoq (Biological) $173.55
- Actemra (Biological) $143.96
- LUPKYNIS (Drug) $118.91
- Cimzia (Drug) $117.26
- ILARIS (Biological) $113.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Santa Barbara
Stuart Segal, M.d, M.D
Rheumatology — Payments: $162,377
Hans Richard Barthel, M.d, M.D
Rheumatology — Payments: $32,207
Christian Powell
Rheumatology — Payments: $21,653
Sara Taroumian, M.d, M.D
Rheumatology — Payments: $17,319
Susan Lemon, Do, DO
Rheumatology — Payments: $14,104
Guy Clark, Md, MD
Rheumatology — Payments: $3,579